[ad_1]
The Dutch decision came after an Irishman discontinued the vaccine, as Dr Ronan Glen, Ireland’s deputy chief medical officer, said the recommendation was made after the Norwegian Medicines Agency reported four cases of blood clots among adults. after receiving the AstraZeneca vaccine.
He added that while there is no conclusive link between the vaccine and the infection, Irish health officials have recommended that the vaccine be discontinued as a precautionary measure.
AstraZeneca said in a statement "A careful review of all potential safety data from more than 17 million people who were vaccinated against Covid-19 with the AstraZeneca vaccine in the European Union and Great Britain showed no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or platelet oligopathy in any age group, sex or specific country. Shows".
Authorities in Denmark, Norway, and Iceland suspended use of the vaccine due to clotting-related problems, while Austria halted use of a batch of doses of AstraZeneca last week pending an investigation into death from bleeding disorders. blood clotting.
For its part, the UK Medicines Regulatory Authority confirmed that "Reports of blood clots are no greater than the number that would have occurred naturally in the vaccinated population, and that "The available evidence does not confirm that a vaccine is the cause."
He claimed that people still needed to get vaccinated when requested.
The European Medicines Agency said there is no evidence that these cases are related to the vaccine, an opinion also addressed by the World Health Organization on Friday.
The company said it and European health authorities had conducted additional tests without showing cause for concern.
He added that there were also no confirmed quality issues for any of the lots. coronavirus vaccine Used in Europe and the world.
Health authorities in the European Union and many countries have approved the use of the AstraZeneca vaccine, which was developed by the company in cooperation with the University of Oxford, but the US regulatory agencies have not yet approved it.
“>
The Dutch decision came after an Irishman discontinued the vaccine, as Dr Ronan Glen, Ireland’s deputy chief medical officer, said the recommendation was made after the Norwegian Medicines Agency reported four cases of blood clots among adults. after receiving the AstraZeneca vaccine.
He added that although there is no conclusive link between the vaccine and infection, Irish health officials have recommended that the vaccine be discontinued as a precautionary measure.
“A careful review of all the potential safety data of more than 17 million people who were vaccinated against Covid-19 with the AstraZeneca vaccine in the European Union and Great Britain has shown no evidence of an increased risk of pulmonary embolism, venous thrombosis depth or platelet count in any specific age group or gender or in any particular country. “
Authorities in Denmark, Norway, and Iceland suspended use of the vaccine due to clotting-related problems, while Austria halted use of a batch of doses of AstraZeneca last week pending an investigation into death from bleeding disorders. blood clotting.
For its part, the UK Medicines Regulatory Authority confirmed that “reports of blood clots do not exceed the number that would have occurred naturally among the vaccinated population, and that” the available evidence does not confirm that the vaccine is the cause. “.
He said people still needed to get vaccinated when requested.
The European Medicines Agency said there is no evidence that these cases are related to the vaccine, an opinion also addressed by the World Health Organization on Friday.
The company said it and the European health authorities had conducted additional tests without showing cause for concern.
He added that there were also no confirmed quality issues for any of the lots. coronavirus vaccine Used in Europe and the world.
Health authorities in the European Union and many countries have approved the use of the AstraZeneca vaccine, which was developed by the company in cooperation with the University of Oxford, but the US regulatory agencies have not yet approved it.
[ad_2]
